lilly tirzepatide vials releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Eli Lilly to sell Zepbound

Research suggests that the peptide may enhance sodium reabsorption in the kidney, leading to increased fluid retention

Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C, Vogelstein B

Research utilizing the Broad Institute's Connectivity Map indicates it influences the expression of over 4,000 genes (~31% of the human genome), shifting gene signatures from a pathological state back to a healthier, regenerative baseline

FINAL DIAGNOSIS Evidence from clinical trials and post-marketing reports points to Victoza (liraglutide) as the component associated with gallbladder-related issues like cholelithiasis (gallstones), cholecystitis, and obstructive (cholestatic) jaundice

In addition to using the medication, I used portion control and dancing as a form of exercise